|
Market Closed -
Nasdaq
16:00:00 2026-10-16 EDT
|
5-day change | 1st Jan Change | ||
| 7.430 USD | -6.89% |
|
-5.83% | -10.86% |
| 08-13 | Rockwell Medical, Inc., Q2 2026 Earnings Call, Aug 13, 2026 | |
| 08-13 | Rockwell Medical, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
| Market Cap | 29.95M 26.62M 24.67M 22.45M 42.36M 2.84B 43.04M 297M 116M 1.48B 112M 110M 4.73B | P/E 2026 * |
-7.36x | P/E 2027 * | -36.2x |
|---|---|---|---|---|---|
| Enterprise Value | 29.95M 26.62M 24.67M 22.45M 42.36M 2.84B 43.04M 297M 116M 1.48B 112M 110M 4.73B | EV / Sales 2026 * |
0.41x | EV / Sales 2027 * | 0.38x |
| Free-Float |
85.22% | Yield 2026 * |
-
| Yield 2027 * | - |
NasdaqUSD
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| RMTI | Delayed | |
CBOE
| RMTI | Real-time |
Last Transcript: Rockwell Medical, Inc.
| 1 day | -6.89% | ||
| 1 week | -5.83% | ||
| Current month | -13.00% | ||
| 1 month | -7.87% | ||
| 3 months | +21.31% | ||
| 6 months | -18.68% | ||
| Current year | -10.86% |
| 1 week | 7.24 |  | 8.24 |
| 1 month | 7.24 | | 8.9 |
| Current year | 4.88 | | 12.9 |
| 1 year | 4.88 | | 12.9 |
| 3 years | 4.88 | | 51.5 |
| 5 years | 4.88 | | 71.5 |
| 10 years | 4.88 | | 987.8 |
| Manager | Title | Age | Since |
|---|---|---|---|
Mark Strobeck
CEO | Chief Executive Officer | 73 | 2022-06-30 |
Jesse Neri
DFI | Director of Finance/CFO | 48 | 2024-12-11 |
Heather Hunter
COO | Chief Operating Officer | 47 | 2025-09-22 |
| Director | Title | Age | Since |
|---|---|---|---|
John Cooper
BRD | Director/Board Member | 67 | 2017-09-06 |
Robert Radie
CHM | Chairman | 73 | 2022-03-31 |
Allen Nissenson
BRD | Director/Board Member | 79 | 2020-06-10 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 10/1/26 | Sell | Chief Executive Officer | -1,000 | 0.0248% | ||
| 7/1/26 | Free | Director | 9,633 | 0.0244% | ||
| 7/1/26 | Free | Chief Financial Officer | 15,000 | 0.0380% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -6.89% | -5.83% | -36.50% | -58.38% | 29.95M | |
| +0.43% | +6.59% | +56.57% | +107.01% | 1,120B | |
| +0.90% | -2.25% | +32.26% | +67.33% | 616B | |
| +0.71% | +3.24% | +24.33% | +91.20% | 504B | |
| -0.13% | +5.98% | +33.66% | +52.01% | 367B | |
| +0.52% | +0.24% | +72.13% | +43.10% | 360B | |
| -0.95% | +4.70% | +19.65% | +43.09% | 288B | |
| -1.98% | +3.73% | -0.89% | +17.28% | 258B | |
| -0.35% | +4.25% | +44.74% | +52.51% | 234B | |
| -0.75% | +3.32% | +27.18% | +96.05% | 194B | |
| Average | -0.85% | +2.67% | +27.31% | +51.12% | 394.09B | |
| Weighted average by Cap. | +0.13% | +3.83% | +39.34% | +73.51% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 72.34M 64.3M 59.6M 54.23M 102M 6.87B 104M 716M 281M 3.58B 271M 266M 11.42B | 78.15M 69.47M 64.39M 58.58M 111M 7.42B 112M 774M 303M 3.87B 293M 287M 12.34B |
| Net income | -3.94M -3.5M -3.24M -2.95M -5.57M -374M -5.66M -38.99M -15.29M -195M -14.78M -14.46M -622M | -914K -812K -753K -685K -1.29M -86.7M -1.31M -9.05M -3.55M -45.24M -3.43M -3.36M -144M |
| Net Debt | - | - |
Employees
157
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-10-16 | US$7.430 | -6.89% | 94,815 |
| 26-10-15 | US$7.980 | +4.18% | 79,793 |
| 26-10-14 | US$7.660 | -2.42% | 15,563 |
| 26-10-13 | US$7.850 | +3.70% | 30,634 |
| 26-10-12 | US$7.570 | -4.06% | 54,249 |
Sell
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
7.430USD
Average target price
20.00USD
Spread / Average Target
+169.18%
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- RMTI Stock
Select your edition
All financial news and data tailored to specific country editions
